Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant

NCT03386305 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Post Liver Transplant

Interventions

DRUG: EnvarsusXR
DRUG: Tacrolimus

Sponsor

Albert Einstein Healthcare Network

Collaborators

[object Object]